Investor profile
Bioqube Ventures has backed 3 European tech companies across 3 funding rounds between 2022 and 2023, joining rounds totalling €36M. Most active in Healthtech and Deeptech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tridek-One | France | 1 | €16M |
| Enhanc3D Genomics | UK | 1 | €11M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Tridek-One | Other | €16M | 2022-09 |
| Enhanc3D Genomics | Series A | €11M | 2022-10 |
| Anavo Therapeutics | Seed | €8.5M | 2023-05 |
